PetMed Express (PETS) Given News Sentiment Score of 0.26
Media headlines about PetMed Express (NASDAQ:PETS) have trended positive recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. PetMed Express earned a news sentiment score of 0.26 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.4484975122439 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:
- PetMed Express Target of Unusually Large Options Trading (PETS) (americanbankingnews.com)
- Just who is EagleBank’s nemesis? Here’s what we know. (bizjournals.com)
- PetMed Express Joins Elite List Of Stocks With 95-Plus Composite Rating (finance.yahoo.com)
- IDEXX Laboratories Banks on Global Prospects, CAG Strength (zacks.com)
- Here’s Why You Should Invest in PetMed (PETS) Stock Now (finance.yahoo.com)
Several research firms recently weighed in on PETS. Craig Hallum reaffirmed a “hold” rating and set a $40.00 target price (down from $43.00) on shares of PetMed Express in a research note on Monday, August 21st. They noted that the move was a valuation call. BidaskClub cut shares of PetMed Express from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 22nd. Sidoti raised shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 target price for the company in a research note on Thursday, August 24th. ValuEngine raised shares of PetMed Express from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Finally, Zacks Investment Research cut shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $42.00.
PetMed Express (NASDAQ:PETS) last issued its quarterly earnings data on Monday, October 23rd. The company reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.13. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The business had revenue of $66.70 million during the quarter, compared to analysts’ expectations of $63.41 million. During the same period last year, the company posted $0.24 EPS. The business’s revenue was up 9.7% on a year-over-year basis. analysts anticipate that PetMed Express will post 1.67 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Friday, November 17th. Investors of record on Monday, November 6th were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, November 3rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.86%. PetMed Express’s dividend payout ratio is presently 53.69%.
In related news, Director Ronald J. Korn sold 1,000 shares of PetMed Express stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $35.57, for a total transaction of $35,570.00. Following the completion of the transaction, the director now directly owns 73,833 shares of the company’s stock, valued at approximately $2,626,239.81. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 4.00% of the stock is currently owned by insiders.
ILLEGAL ACTIVITY NOTICE: “PetMed Express (PETS) Given News Sentiment Score of 0.26” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/08/petmed-express-pets-given-news-sentiment-score-of-0-26.html.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.